APO RESEARCH · REPORT
Transdermal Drug Patches
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Product & engineering
Understand the product.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Selected research
Industry Research
Transdermal Drug Patches Industry Research Report 2026
Market perspective
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
The major players in global Transdermal Drug Patches market include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, etc. The top 3 players occupy about 35% shares of the global market. America and Europe are main markets, they occupy about 75% of the global market. Methyl Salicylate-based Patch is the main type, with a share over 15%. Rx Channel is the main application, which holds a share about 90%.
Report Scope
Read the full market overview
This report quantifies the global Transdermal Drug Patches market in terms of revenue (US$ million) and, where applicable, sales volume (M Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Transdermal Drug Patches Market by Company
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Transdermal Drug Patches Segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Transdermal Drug Patches Segment by Application
Rx Channel
OTC Channel
Transdermal Drug Patches Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Drug Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Drug Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Drug Patches.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Transdermal Drug Patches manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Transdermal Drug Patches by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Transdermal Drug Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Methyl Salicylate-based Patch
- Rivastigmine Transdermal Patch
- Fentanyl Transdermal Patch
- Lidocaine Patch
- Diclofenac Patch
- Nicotine Transdermal Patch
- Others
Applications
- Rx Channel
- OTC Channel
Companies covered
- Hisamitsu Pharmaceutical
- Johnson & Johnson
- Novartis
- UCB Pharma
- Mylan
- Teva Pharmaceutical
- Nitto Denko
- Grünenthal
- IBSA Group
- GSK
- Luye Pharma Group
- Pfizer
- Chattem
- Dr Reddy’s Laboratories
- Bayer
- Mundipharma
- Endo International
- Beijing Tide Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Transdermal Drug Patches Market Size (2021-2032)
- 2.2.2 Global Transdermal Drug Patches Sales (2021-2032)
- 2.2.3 Global Transdermal Drug Patches Market Average Price (2021-2032)
- 2.3 Transdermal Drug Patches by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Methyl Salicylate-based Patch
- 2.3.3 Rivastigmine Transdermal Patch
- 2.3.4 Fentanyl Transdermal Patch
- 2.3.5 Lidocaine Patch
- 2.3.6 Diclofenac Patch
- 2.3.7 Nicotine Transdermal Patch
- 2.3.8 Others
- 2.4 Transdermal Drug Patches by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Rx Channel
- 2.4.3 OTC Channel
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Transdermal Drug Patches Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Transdermal Drug Patches Sales (M Pcs) of Manufacturers (2021-2026)
- 3.3 Global Transdermal Drug Patches Revenue of Manufacturers (2021-2026)
- 3.4 Global Transdermal Drug Patches Average Price by Manufacturers (2021-2026)
- 3.5 Global Transdermal Drug Patches Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Transdermal Drug Patches, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Transdermal Drug Patches, Product Type & Application
- 3.8 Global Manufacturers of Transdermal Drug Patches, Established Date
- 3.9 Global Transdermal Drug Patches Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Hisamitsu Pharmaceutical
- 4.1.1 Hisamitsu Pharmaceutical Company Information
- 4.1.2 Hisamitsu Pharmaceutical Business Overview
- 4.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Product Portfolio
- 4.1.5 Hisamitsu Pharmaceutical Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Transdermal Drug Patches Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Transdermal Drug Patches Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 UCB Pharma
- 4.4.1 UCB Pharma Company Information
- 4.4.2 UCB Pharma Business Overview
- 4.4.3 UCB Pharma Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 UCB Pharma Transdermal Drug Patches Product Portfolio
- 4.4.5 UCB Pharma Recent Developments
- 4.5 Mylan
- 4.5.1 Mylan Company Information
- 4.5.2 Mylan Business Overview
- 4.5.3 Mylan Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mylan Transdermal Drug Patches Product Portfolio
- 4.5.5 Mylan Recent Developments
- 4.6 Teva Pharmaceutical
- 4.6.1 Teva Pharmaceutical Company Information
- 4.6.2 Teva Pharmaceutical Business Overview
- 4.6.3 Teva Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Teva Pharmaceutical Transdermal Drug Patches Product Portfolio
- 4.6.5 Teva Pharmaceutical Recent Developments
- 4.7 Nitto Denko
- 4.7.1 Nitto Denko Company Information
- 4.7.2 Nitto Denko Business Overview
- 4.7.3 Nitto Denko Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Nitto Denko Transdermal Drug Patches Product Portfolio
- 4.7.5 Nitto Denko Recent Developments
- 4.8 Grünenthal
- 4.8.1 Grünenthal Company Information
- 4.8.2 Grünenthal Business Overview
- 4.8.3 Grünenthal Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Grünenthal Transdermal Drug Patches Product Portfolio
- 4.8.5 Grünenthal Recent Developments
- 4.9 IBSA Group
- 4.9.1 IBSA Group Company Information
- 4.9.2 IBSA Group Business Overview
- 4.9.3 IBSA Group Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 IBSA Group Transdermal Drug Patches Product Portfolio
- 4.9.5 IBSA Group Recent Developments
- 4.10 GSK
- 4.10.1 GSK Company Information
- 4.10.2 GSK Business Overview
- 4.10.3 GSK Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 GSK Transdermal Drug Patches Product Portfolio
- 4.10.5 GSK Recent Developments
- 4.11 Luye Pharma Group
- 4.11.1 Luye Pharma Group Company Information
- 4.11.2 Luye Pharma Group Business Overview
- 4.11.3 Luye Pharma Group Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Luye Pharma Group Transdermal Drug Patches Product Portfolio
- 4.11.5 Luye Pharma Group Recent Developments
- 4.12 Pfizer
- 4.12.1 Pfizer Company Information
- 4.12.2 Pfizer Business Overview
- 4.12.3 Pfizer Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Pfizer Transdermal Drug Patches Product Portfolio
- 4.12.5 Pfizer Recent Developments
- 4.13 Chattem
- 4.13.1 Chattem Company Information
- 4.13.2 Chattem Business Overview
- 4.13.3 Chattem Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Chattem Transdermal Drug Patches Product Portfolio
- 4.13.5 Chattem Recent Developments
- 4.14 Dr Reddy’s Laboratories
- 4.14.1 Dr Reddy’s Laboratories Company Information
- 4.14.2 Dr Reddy’s Laboratories Business Overview
- 4.14.3 Dr Reddy’s Laboratories Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Dr Reddy’s Laboratories Transdermal Drug Patches Product Portfolio
- 4.14.5 Dr Reddy’s Laboratories Recent Developments
- 4.15 Bayer
- 4.15.1 Bayer Company Information
- 4.15.2 Bayer Business Overview
- 4.15.3 Bayer Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Bayer Transdermal Drug Patches Product Portfolio
- 4.15.5 Bayer Recent Developments
- 4.16 Mundipharma
- 4.16.1 Mundipharma Company Information
- 4.16.2 Mundipharma Business Overview
- 4.16.3 Mundipharma Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Mundipharma Transdermal Drug Patches Product Portfolio
- 4.16.5 Mundipharma Recent Developments
- 4.17 Endo International
- 4.17.1 Endo International Company Information
- 4.17.2 Endo International Business Overview
- 4.17.3 Endo International Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Endo International Transdermal Drug Patches Product Portfolio
- 4.17.5 Endo International Recent Developments
- 4.18 Beijing Tide Pharmaceutical
- 4.18.1 Beijing Tide Pharmaceutical Company Information
- 4.18.2 Beijing Tide Pharmaceutical Business Overview
- 4.18.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Product Portfolio
- 4.18.5 Beijing Tide Pharmaceutical Recent Developments
5 Global Transdermal Drug Patches Market Scenario by Region
- 5.1 Global Transdermal Drug Patches Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Transdermal Drug Patches Sales by Region: 2021-2032
- 5.2.1 Global Transdermal Drug Patches Sales by Region: 2021-2026
- 5.2.2 Global Transdermal Drug Patches Sales by Region: 2027-2032
- 5.3 Global Transdermal Drug Patches Revenue by Region: 2021-2032
- 5.3.1 Global Transdermal Drug Patches Revenue by Region: 2021-2026
- 5.3.2 Global Transdermal Drug Patches Revenue by Region: 2027-2032
- 5.4 North America Transdermal Drug Patches Market Facts & Figures by Country
- 5.4.1 North America Transdermal Drug Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Transdermal Drug Patches Sales by Country (2021-2032)
- 5.4.3 North America Transdermal Drug Patches Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Transdermal Drug Patches Market Facts & Figures by Country
- 5.5.1 Europe Transdermal Drug Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Transdermal Drug Patches Sales by Country (2021-2032)
- 5.5.3 Europe Transdermal Drug Patches Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Transdermal Drug Patches Market Facts & Figures by Country
- 5.6.1 Asia Pacific Transdermal Drug Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Transdermal Drug Patches Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Transdermal Drug Patches Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Transdermal Drug Patches Market Facts & Figures by Country
- 5.7.1 South America Transdermal Drug Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Transdermal Drug Patches Sales by Country (2021-2032)
- 5.7.3 South America Transdermal Drug Patches Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Transdermal Drug Patches Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Transdermal Drug Patches Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Transdermal Drug Patches Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Transdermal Drug Patches Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Transdermal Drug Patches Sales by Type (2021-2032)
- 6.1.1 Global Transdermal Drug Patches Sales by Type (2021-2032) & (M Pcs)
- 6.1.2 Global Transdermal Drug Patches Sales Market Share by Type (2021-2032)
- 6.2 Global Transdermal Drug Patches Revenue by Type (2021-2032)
- 6.2.1 Global Transdermal Drug Patches Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Transdermal Drug Patches Revenue Market Share by Type (2021-2032)
- 6.3 Global Transdermal Drug Patches Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Transdermal Drug Patches Sales by Application (2021-2032)
- 7.1.1 Global Transdermal Drug Patches Sales by Application (2021-2032) & (M Pcs)
- 7.1.2 Global Transdermal Drug Patches Sales Market Share by Application (2021-2032)
- 7.2 Global Transdermal Drug Patches Revenue by Application (2021-2032)
- 7.2.1 Global Transdermal Drug Patches Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Transdermal Drug Patches Revenue Market Share by Application (2021-2032)
- 7.3 Global Transdermal Drug Patches Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Transdermal Drug Patches Value Chain Analysis
- 8.1.1 Transdermal Drug Patches Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Transdermal Drug Patches Production Mode & Process
- 8.2 Transdermal Drug Patches Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Transdermal Drug Patches Distributors
- 8.2.3 Transdermal Drug Patches Customers
9 Global Transdermal Drug Patches Analyzing Market Dynamics
- 9.1 Transdermal Drug Patches Industry Trends
- 9.2 Transdermal Drug Patches Industry Drivers
- 9.3 Transdermal Drug Patches Industry Opportunities and Challenges
- 9.4 Transdermal Drug Patches Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst